1. ERp44 Exerts Redox-Dependent Control of Blood Pressure at the ER.
- Author
-
Hisatsune C, Ebisui E, Usui M, Ogawa N, Suzuki A, Mataga N, Takahashi-Iwanaga H, and Mikoshiba K
- Subjects
- Amino Acid Sequence, Aminopeptidases genetics, Angiotensin II blood, Angiotensin II metabolism, Animals, Blotting, Western, Cells, Cultured, HeLa Cells, Humans, Membrane Proteins genetics, Mice, Inbred C57BL, Mice, Knockout, Minor Histocompatibility Antigens, Molecular Chaperones genetics, Molecular Sequence Data, Oxidation-Reduction, Protein Binding, RNA Interference, Sequence Homology, Amino Acid, Aminopeptidases metabolism, Blood Pressure, Endoplasmic Reticulum metabolism, Membrane Proteins metabolism, Molecular Chaperones metabolism
- Abstract
Blood pressure maintenance is vital for systemic homeostasis, and angiotensin II is a critical regulator. The upstream mechanisms that regulate angiotensin II are not completely understood. Here, we show that angiotensin II is regulated by ERp44, a factor involved in disulfide bond formation in the ER. In mice, genetic loss of ERp44 destabilizes angiotensin II and causes hypotension. We show that ERp44 forms a mixed disulfide bond with ERAP1, an aminopeptidase that cleaves angiotensin II. ERp44 controls the release of ERAP1 in a redox-dependent manner to control blood pressure. Additionally, we found that systemic inflammation triggers ERAP1 retention in the ER to inhibit hypotension. These findings suggest that the ER redox state calibrates serum angiotensin II levels via regulation of the ERp44-ERAP1 complex. Our results reveal a link between ER function and normotension and implicate the ER redox state as a potential risk factor in the development of cardiovascular disease., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF